Literature DB >> 33989420

Corticosteroids for treating mild COVID-19: Opening the floodgates of therapeutic misadventure.

Animesh Ray1, Ayush Goel1, Naveet Wig1.   

Abstract

Entities:  

Keywords:  Covid-19; India; Steroids

Year:  2021        PMID： 33989420     DOI： 10.1093/qjmed/hcab138

Source DB:  PubMed          Journal:  QJM        ISSN： 1460-2393


× No keyword cloud information.
  4 in total

1.  COVID-19-associated subacute invasive pulmonary aspergillosis.

Authors:  Satish Swain; Animesh Ray; Radhika Sarda; Surabhi Vyas; Gagandeep Singh; Pankaj Jorwal; Parul Kodan; Puneet Khanna; Immaculata Xess; Sanjeev Sinha; Naveet Wig; Anjan Trikha
Journal:  Mycoses       Date:  2021-09-29       Impact factor: 4.931

2.  COVID-19 and chronic diabetes: the perfect storm for reactivation tuberculosis?: a case series.

Authors:  Genesis P Aguillón-Durán; Ericka Prieto-Martínez; Doris Ayala; Juan García; John M Thomas; Juan Ignacio García; Brandon Michael Henry; Jordi B Torrelles; Joanne Turner; Eder Ledezma-Campos; Blanca I Restrepo
Journal:  J Med Case Rep       Date:  2021-12-16

3.  Corticosteroids for mild COVID-19 treatment: Opening the floodgates of therapeutic benefits.

Authors:  Nicholas G Kounis; Sophia N Kouni; Virginia Mplani; Ioanna Koniari
Journal:  QJM       Date:  2021-12-10

4.  Steroids in mild COVID-19-reading between the lines!

Authors:  Ayush Goel; Animesh Ray
Journal:  QJM       Date:  2021-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.